CA1089360A - Antigen or antibody testing using inhibition of the agglutination of two particulate reagents - Google Patents
Antigen or antibody testing using inhibition of the agglutination of two particulate reagentsInfo
- Publication number
- CA1089360A CA1089360A CA292,691A CA292691A CA1089360A CA 1089360 A CA1089360 A CA 1089360A CA 292691 A CA292691 A CA 292691A CA 1089360 A CA1089360 A CA 1089360A
- Authority
- CA
- Canada
- Prior art keywords
- particulate
- agglutination
- substance
- reagents
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 68
- 230000004520 agglutination Effects 0.000 title claims abstract description 36
- 239000000427 antigen Substances 0.000 title abstract description 4
- 102000036639 antigens Human genes 0.000 title abstract description 4
- 108091007433 antigens Proteins 0.000 title abstract description 4
- 230000005764 inhibitory process Effects 0.000 title description 7
- 238000012360 testing method Methods 0.000 title description 6
- 239000004816 latex Substances 0.000 claims abstract description 31
- 229920000126 latex Polymers 0.000 claims abstract description 31
- 238000003556 assay Methods 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 239000002245 particle Substances 0.000 claims description 55
- 238000000034 method Methods 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 22
- 239000000562 conjugate Substances 0.000 claims description 18
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 230000027455 binding Effects 0.000 claims description 12
- 238000009739 binding Methods 0.000 claims description 12
- 241000283690 Bos taurus Species 0.000 claims description 8
- 229960003387 progesterone Drugs 0.000 claims description 8
- 239000000186 progesterone Substances 0.000 claims description 8
- 230000003287 optical effect Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 238000005065 mining Methods 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 description 12
- 241000282414 Homo sapiens Species 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 229960005156 digoxin Drugs 0.000 description 10
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 9
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 9
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 229940027941 immunoglobulin g Drugs 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 4
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000011236 particulate material Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229940034208 thyroxine Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- 101710125089 Bindin Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 2
- 206010027146 Melanoderma Diseases 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical compound COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101100536931 Escherichia coli (strain K12) thiD gene Proteins 0.000 description 1
- 101100159279 Escherichia coli (strain K12) yajL gene Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940036626 digox Drugs 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000050459 human LTF Human genes 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000002226 simultaneous effect Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5174076A GB1590525A (en) | 1976-12-10 | 1976-12-10 | Biological analysis |
| GB51740/76 | 1976-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1089360A true CA1089360A (en) | 1980-11-11 |
Family
ID=10461194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA292,691A Expired CA1089360A (en) | 1976-12-10 | 1977-12-08 | Antigen or antibody testing using inhibition of the agglutination of two particulate reagents |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS53104726A (enrdf_load_stackoverflow) |
| CA (1) | CA1089360A (enrdf_load_stackoverflow) |
| DE (1) | DE2754645C2 (enrdf_load_stackoverflow) |
| FR (1) | FR2392387A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1590525A (enrdf_load_stackoverflow) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191739A (en) * | 1977-10-17 | 1980-03-04 | General Electric Company | Antigen-antibody reaction assay employing particle aggregation and resistive pulse analysis |
| GB2045431B (en) * | 1979-02-26 | 1983-04-20 | Technicon Instr | Immunoassay utilising two particulate reagents |
| DE2918342A1 (de) * | 1979-05-07 | 1980-11-20 | Behringwerke Ag | Latex-reagenz |
| JPS5821166A (ja) * | 1981-07-30 | 1983-02-07 | Fujitsu Ltd | 被測定物質分離方式 |
| DE3212658C3 (de) * | 1982-04-05 | 1993-08-19 | American Hospital Supply Corp | Verfahren zur antigen-bestimmung |
| GB2123146B (en) * | 1982-06-28 | 1985-09-25 | Abbott Lab | Dual parameter flow immunoassays |
| JPH0619349B2 (ja) * | 1983-11-22 | 1994-03-16 | 東亜医用電子株式会社 | 体液成分分析方法およびその装置 |
| JPH0619350B2 (ja) * | 1984-05-17 | 1994-03-16 | 東亜医用電子株式会社 | 体液成分分析方法およびその装置 |
| JPS61120060A (ja) * | 1984-11-16 | 1986-06-07 | Dai Ichi Pure Chem Co Ltd | 全自動連続分析装置 |
| GB8717862D0 (en) * | 1987-07-28 | 1987-09-03 | Acade Diagnostic Systems Sa Nv | Turbidimetric assay |
| CN111965277A (zh) * | 2020-08-06 | 2020-11-20 | 天津科德通生物科技有限公司 | 一种抗体纯化流出液自动收集装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639558A (en) * | 1968-02-19 | 1972-02-01 | Louis Csizmas | Immunological reagent particles having proteinaceous materials covalently bonded thereto |
-
1976
- 1976-12-10 GB GB5174076A patent/GB1590525A/en not_active Expired
-
1977
- 1977-12-08 CA CA292,691A patent/CA1089360A/en not_active Expired
- 1977-12-08 DE DE19772754645 patent/DE2754645C2/de not_active Expired
- 1977-12-09 FR FR7737122A patent/FR2392387A1/fr active Granted
- 1977-12-10 JP JP14777277A patent/JPS53104726A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2754645A1 (de) | 1978-06-22 |
| FR2392387B1 (enrdf_load_stackoverflow) | 1982-05-14 |
| GB1590525A (en) | 1981-06-03 |
| FR2392387A1 (fr) | 1978-12-22 |
| JPS6217188B2 (enrdf_load_stackoverflow) | 1987-04-16 |
| DE2754645C2 (de) | 1986-11-20 |
| JPS53104726A (en) | 1978-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4184849A (en) | Mixed agglutination | |
| US4279617A (en) | Iummunoassay involving agglutination | |
| US4313734A (en) | Metal sol particle immunoassay | |
| JP2890384B2 (ja) | 固相イムノアッセイ法 | |
| US4847199A (en) | Agglutination immunoassay and kit for determination of a multivalent immune species using a buffered salt wash solution | |
| RU2025732C1 (ru) | Способ иммуноанализа аналита в водном образце | |
| EP0267317B1 (en) | Method for the detection of proteins and viruses | |
| CN100476437C (zh) | 减少钩效应的流通测定装置及检测方法 | |
| EP0124352B1 (en) | Protected binding assay | |
| US5270166A (en) | Immunoassays employing generic anti-hapten antibodies and materials for use therein | |
| PL196464B1 (pl) | Analityczne urządzenie chromatograficzne oraz sposób wykrywania obecności przedmiotu analizy w próbce krwi | |
| JP2000503404A (ja) | 基準微小粒子を使用する検定 | |
| CN111413501A (zh) | 一种检测试纸条在制备检测thsd7a抗体的试剂盒中的应用 | |
| CA1174596A (en) | Particle agglutination assay | |
| TW594010B (en) | Internal calibration system for flow-through assays | |
| WO1995015498A1 (en) | Immunoassays employing generic anti-hapten antibodies and materials for use therein | |
| CA2109924A1 (en) | Reagents containing a nonspecific binding blocker in ion-capture binding assays | |
| CA1089360A (en) | Antigen or antibody testing using inhibition of the agglutination of two particulate reagents | |
| NO311112B1 (no) | Fremgangsmåte for påvisning av en analytt i en pröve, et utstyrsett for denne, fremgangsmåte for fremstilling avsuperaggregat kompleks av et protein og en gull sol og etsuperaggregert kompleks | |
| CA1288339C (en) | Agglutination reagent and method of preparing same | |
| JP2001033454A (ja) | 多孔質固相リガンド測定試験片上における被検物質の定量法および装置 | |
| EP1064552B1 (en) | Immunoassays using casein coating of particles | |
| US4713350A (en) | Hydrophilic assay reagent containing one member of specific binding pair | |
| EP0280561B1 (en) | Agglutination reagent and method of preparing same | |
| JPH08220099A (ja) | 物質の検出試薬及び慢性関節リウマチの検知法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |